These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 2432080

  • 1. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 2. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 3. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR.
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 5. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 6. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 7. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [Abstract] [Full Text] [Related]

  • 8. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 9. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ, Buck RH, Joubert SM.
    S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Apr 01; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 11. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb 01; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 12. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K, Uesato T, Kato K.
    Endocrinol Jpn; 1986 Oct 01; 33(5):727-33. PubMed ID: 3030714
    [Abstract] [Full Text] [Related]

  • 13. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T, Matsuura S, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct 01; 35(10):1759-66. PubMed ID: 6195275
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 01; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 15. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
    Nishimura R, Ashitaka Y, Tojo S.
    Endocrinol Jpn; 1979 Oct 01; 26(5):575-83. PubMed ID: 527560
    [Abstract] [Full Text] [Related]

  • 16. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
    Ozturk M.
    J Reprod Med; 1991 Jan 01; 36(1):21-6. PubMed ID: 1706779
    [Abstract] [Full Text] [Related]

  • 17. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T, Mochizuki M, Nishimura R.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar 01; 43(3):297-303. PubMed ID: 1710641
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Mar 01; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 19. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
    Shapiro AI, Wu TF, Ballon SC, Lamb EJ.
    Obstet Gynecol; 1985 Apr 01; 65(4):545-9. PubMed ID: 2580254
    [Abstract] [Full Text] [Related]

  • 20. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit.
    Kardana A, Cole LA.
    Clin Chem; 1992 Jan 01; 38(1):26-33. PubMed ID: 1370771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.